AAAAAA

   
Results: 1-14 |
Results: 14
Evaluation of a device for negative selection of CD34+cells alone or in combination with breast cancer tumor cell purging
Authors: Trummer, A Hertenstein, B Lichtinghagen, R Ganser, A Arseniev, L
Citation: A. Trummer et al., Evaluation of a device for negative selection of CD34+cells alone or in combination with breast cancer tumor cell purging, INFUS THER, 28(2), 2001, pp. 67-72
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia
Authors: Hambach, L Eder, M Dammann, E Battmer, K Stucki, A Heil, G Ganser, A Hertenstein, B
Citation: L. Hambach et al., Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia, BONE MAR TR, 28(7), 2001, pp. 705-707
Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation - Results of a prospective study
Authors: Tschuschke, V Hertenstein, B Arnold, R Bunjes, D Denzinger, R Kaechele, H
Citation: V. Tschuschke et al., Associations between coping and survival time of adult leukemia patients receiving allogeneic bone marrow transplantation - Results of a prospective study, J PSYCHOSOM, 50(5), 2001, pp. 277-285
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis
Authors: Bornhauser, M Kiehl, M Siegert, W Schetelig, J Hertenstein, B Martin, H Schwerdtfeger, R Sayer, HG Runde, V Kroger, N Theuser, C Ehninger, G
Citation: M. Bornhauser et al., Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis, BR J HAEM, 115(1), 2001, pp. 119-124
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
Authors: Binks, M Passweg, JR Furst, D McSweeney, P Sullivan, K Besenthal, C Finke, J Peter, HH van Laar, J Breedveld, FC Fibbe, VE Farge, D Gluckman, E Locatelli, F Martini, A van den Hoogen, F van de Putte, L Schattenberg, AVN Arnold, R Bacon, PA Emery, P Espigado, I Hertenstein, B Hiepe, F Kashyap, A Kotter, I Marmont, A Martinez, A Pascual, MJ Gratwohl, A Prentice, HG Black, C Tyndall, A
Citation: M. Binks et al., Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease, ANN RHEUM D, 60(6), 2001, pp. 577-584
Complete haematological and cytogenetic response to interferon alpha-2a ofa myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration
Authors: Schoffski, P Ganser, A Pascheberg, U Busche, G Gaede, B Hertenstein, B
Citation: P. Schoffski et al., Complete haematological and cytogenetic response to interferon alpha-2a ofa myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration, ANN HEMATOL, 79(2), 2000, pp. 95-98
HLA-DR4 is associated with a diminished risk of the development of chronicmyeloid leukemia (CML)
Authors: Posthuma, EFM Falkenburg, JHF Apperley, JF Gratwohl, A Hertenstein, B Schipper, RF Oudshoorn, M von Biezen, JH Hermans, J Willemze, R Roosnek, E Niederwieser, D
Citation: Efm. Posthuma et al., HLA-DR4 is associated with a diminished risk of the development of chronicmyeloid leukemia (CML), LEUKEMIA, 14(5), 2000, pp. 859-862
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation
Authors: Comi, G Kappos, L Clanet, M Ebers, G Fassas, A Fazekas, F Filippi, M Hartung, HP Hertenstein, B Karussis, D Martino, G Tyndall, A van der Meche, FGA
Citation: G. Comi et al., Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation, J NEUROL, 247(5), 2000, pp. 376-382
Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors andoutcome
Authors: Duncker, C Dohr, D von Harsdorf, S Duyster, J Stefanic, M Martini, C Treiber, M Hertenstein, B Novotny, J Arnold, R Heimpel, H Bergmann, L Bunjes, D
Citation: C. Duncker et al., Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors andoutcome, BONE MAR TR, 25(12), 2000, pp. 1263-1268
Treatment of lymphoproliferative disease with rituximab
Authors: Niedermeyer, J Hoffmeyer, F Hertenstein, B Hoeper, MM Fabel, H
Citation: J. Niedermeyer et al., Treatment of lymphoproliferative disease with rituximab, LANCET, 355(9202), 2000, pp. 499-499
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
Authors: Champlin, RE Schmitz, N Horowitz, MM Chapuis, B Chopra, R Cornelissen, JJ Gale, RP Goldman, JM Loberiza, FR Hertenstein, B Klein, JP Montserrat, E Zhang, MJ Ringden, O Tomany, SC Rowlings, PA Van Hoef, MEHM Gratwohl, A
Citation: Re. Champlin et al., Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation, BLOOD, 95(12), 2000, pp. 3702-3709
Comparative evaluation of commonly used clones and fluorochrome conjugatesof monoclonal antibodies for CD34 antigen detection
Authors: Arseniev, L Pickerd, N Goudeva, L Hertenstein, B Ganser, A
Citation: L. Arseniev et al., Comparative evaluation of commonly used clones and fluorochrome conjugatesof monoclonal antibodies for CD34 antigen detection, J HEMATH ST, 8(5), 1999, pp. 547-559
Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation
Authors: Eder, M Battmer, K Kafert, S Stucki, A Ganser, A Hertenstein, B
Citation: M. Eder et al., Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation, LEUKEMIA, 13(9), 1999, pp. 1383-1389
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia
Authors: Posthuma, EFM Falkenburg, JHF Apperley, JF Gratwohl, A Roosnek, E Hertenstein, B Schipper, RF Schreuder, GMT D'Amaro, J Oudshoorn, M von Biezen, JH Hermans, J Willemze, R Niederwieser, D
Citation: Efm. Posthuma et al., HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia, BLOOD, 93(11), 1999, pp. 3863-3865
Risultati: 1-14 |